Pre-clinical studies using TSPO PET ligands for in vivo imaging of gliomas revealed promising results [207,208], which were corroborated in humans by first-generation PET-tracers such as 11C-PK11195 [209,210]. The gene discussed is TSPO; the disease is central nervous system cancer.